Ultrasound diagnosis of calcium pyrophosphate deposition disease
https://doi.org/10.24835/1607-0771-337
Abstract
Calcium pyrophosphate deposition disease (CPPD) is one of the most common inflammatory arthropathies. It is characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals within joints and periarticular tissues. In routine clinical practice, imaging plays a central role in the diagnosis of CPPD. In recent years, ultrasound has emerged as a leading modality for early detection of crystal deposits across various anatomical regions, for monitoring disease progression, and for guiding aspiration procedures. The article presents a pictorial literature review highlighting the role of ultrasound in the diagnosis of calcium pyrophosphate deposition disease. Based on current clinical recommendations, the main ultrasound features of CPPD are described (detection of calcium pyrophosphate deposits in fibrous and hyaline cartilage, tendons, joint capsule, and intra-articular contents) allowing for correct interpretation of findings for timely diagnosis, differential diagnosis, and dynamical assessment during therapy.
About the Author
E. V. Polukhina
Postgraduate Institute for Public Health Workers; 9, Krasnodarskaya str., Khabarovsk 680009, Russian Federation
Russian Federation
Russian Federation
Elena V. Polukhina – MD, Doct. of Sci. (Med.), Associate Professor, Professor of Division of Rаdiology and Functional Diagnostics, Postgraduate Institute for Public Health Workers, Khabarovsk
https://orcid.org/0000-0002-8760-4880
References
1. Rosenthal A.K., Ryan LM. Calcium Pyrophosphate Deposition Disease. N. Engl. J. Med. 2016; 374 (26): 2575–2584. http://doi.org/10.1056/NEJMra1511117
2. Zhang W., Doherty M., Bardin T. et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann. Rheum. Dis. 2011; 70 (4): 563–570. http://doi.org/10.1136/ard.2010.139105
3. Abhishek A. Calcium pyrophosphate deposition disease: a review of epidemiologic findings. Curr. Opin. Rheumatol. 2016; 28 (2): 133–139. http://doi.org/10.1097/BOR.0000000000000246
4. Beutler A., Rothfuss S., Clayburne G. et al. Calcium pyrophosphate dihydrate crystal deposition in synovium. Relationship to collagen fibers and chondrometaplasia. Arthritis Rheum. 1993; 36 (5): 704–715. http://doi.org/10.1002/art.1780360520
5. Sirotti S., Gutierrez M., Pineda C. et al. Accuracy of synovial fluid analysis compared to histology for the identification of calcium pyrophosphate crystals: an ancillary study of the OMERACT US Working Group – CPPD subgroup. Reumatismo. 2021; 73 (2): 106–110. http://doi.org/10.4081/reumatismo.2021.1403
6. Tedeschi S.K., Becce F., Pascart T. et al. Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working Group. Arthritis Care Res. (Hoboken). 2023; 75 (4): 825–834. http://doi.org/10.1002/acr.24898
7. Cipolletta E., Filippou G., Scirè C.A. et al. The diagnostic value of conventional radiography and musculoskeletal ultrasonography in calcium pyrophosphate deposition disease: a systematic literature review and meta-analysis. Osteoarthritis Cartilage. 2021; 29 (5): 619–632. http://doi.org/10.1016/j.joca.2021.01.007
8. Filippou G., Sirotti S. How can ultrasonography help in the management of CPPD? From diagnosis to clinical subset identification. Curr. Opin. Rheumatol. 2023; 35 (3): 185–193. http://doi.org/10.1097/BOR.0000000000000939
9. Coari G., Iagnocco A., Zoppini A. Chondrocalcinosis: sonographic study of the knee. Clin. Rheumatol. 1995; 14 (5): 511–514. http://doi.org/10.1007/BF02208146
10. Grassi W., Meenagh G., Pascual E., Filippucci E. “Crystal clear”-sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin. Arthritis Rheum. 2006; 36 (3): 197–202. http://doi.org/10.1016/j.semarthrit.2006.08.001
11. Abhishek A, Tedeschi S.K., Pascart T. et al. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis Rheumatol. 2023; 75 (10): 1703–1713. http://doi.org/10.1002/art.42619
12. Filippou G., Scirè C.A., Damjanov N. et al. Definition and Reliability Assessment of Elementary Ultrasonographic Findings in Calcium Pyrophosphate Deposition Disease: A Study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force. J. Rheumatol. 2017; 44 (11): 1744–1749. http://doi.org/10.3899/jrheum.161057
13. Cipolletta E., Moscioni E., Sirotti S. et al. Diagnosis of calcium pyrophosphate crystal deposition disease by ultrasonography: how many and which sites should be scanned? Rheumatology (Oxford). 2024; 1; 63 (8): 2205–2212. http://doi.org/10.1093/rheumatology/kead565
14. Adinolfi A., Sirotti S., Sakellariou G. et al. Which are the most frequently involved peripheral joints in calcium pyrophosphate crystal deposition at imaging? A systematic literature review and meta-analysis by the OMERACT ultrasound – CPPD subgroup. Front. Med. (Lausanne). 2023; 9; 10: 1131362. http://doi.org/10.3389/fmed.2023.1131362
15. Filippou G., Scanu A., Adinolfi A. et al. Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study. Ann. Rheum. Dis. 2021; 80 (2): 261–267. http://doi.org/10.1136/annrheumdis-2020-217998
16. Lee K.A., Lee S.H., Kim H.R. Diagnostic value of ultrasound in calcium pyrophosphate deposition disease of the knee joint. Osteoarthritis Cartilage. 2019; 27 (5):781–787. http://doi.org/10.1016/j.joca.2018.11.013
17. Cipolletta E., Smerilli G., Mashadi Mirza R. et al. Sonographic assessment of calcium pyrophosphate deposition disease at wrist. A focus on the dorsal scapho-lunate ligament. Joint Bone Spine. 2020; 87 (6): 611–617. http://doi.org/10.1016/j.jbspin.2020.04.012
18. Filippou G., Sirotti S., Cipolletta E., Filippucci E. Optimizing the Use of Ultrasound in Calcium Pyrophosphate Deposition (CPPD): A Review from the Ground Up. Gout Urate Cryst. Depos. Dis. 2024; 2: 17–33. https://doi.org/10.3390/gucdd2010002
19. Cipolletta E., Di Matteo A., Smerilli G. et al. Ultrasound findings of calcium pyrophosphate deposition disease at metacarpophalangeal joints. Rheumatology (Oxford). 2022; 61 (10): 3997–4005. https://doi.org/10.1093/rheumatology/keac063
20. Filippucci E., Riveros M.G., Georgescu D. et al. Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound study. Osteoarthritis Cartilage. 2009; 17 (2): 178–181. https://doi.org/10.1016/j.joca.2008.06.003
21. Kenneth P.H. Articular Pathology of Gout, Calcium Pyrophosphate Dihydrate and Basic Calcium Phosphate Crystal Deposition Arthropathies. Editor(s): Robert Terkeltaub, Gout and Other Crystal Arthropathies. 2012; 2–19. https://doi.org/10.1016/B978-1-4377-2864-4.10001-6
22. Filippou G., Miguel-Pérez M., Coronel L. et al. EULAR Study Group on Anatomy for the Image. The ultrasonographic pseudo-double contour sign in calcium pyrophosphate deposition disease: an anatomic explanation and how to distinguish it from gout. Arthritis Rheumatol. 2023; 75 (4): 639–640. https://doi.org/10.1002/art.42397
23. Cipolletta E., Abhishek A., Di Matteo A. et al. Dynamic assessment of the double contour sign by ultrasonography helps to distinguish between gout and calcium pyrophosphate deposition disease. RMD Open. 2023; 9 (1): e002940. https://doi.org/10.1136/rmdopen-2022-002940
24. Filippou G., Pacini G., Sirotti S. et al. Comparison of ultrasound attenuation by calcium pyrophosphate, hydroxyapatite and monosodium urate crystals: a proof-of-concept study. Ann. Rheum. Dis. 2022; 81 (8): 1199–1201. https://doi.org/10.1136/annrheumdis-2022-222316
25. Sirotti S., Terslev L., Filippucci E. et al.; OMERACT Ultrasound working group-CPPD subgroup. Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level. Lancet Rheumatol. 2023; 5 (8): e474–e482. https://doi.org/10.1016/S2665-9913(23)00136-4
Review
For citations:
Polukhina E.V. Ultrasound diagnosis of calcium pyrophosphate deposition disease. Ultrasound & Functional Diagnostics. 2025;31(4):93-104. (In Russ.) https://doi.org/10.24835/1607-0771-337
Views:
201
Email this article 